Cahill Represents Lead Arrangers in $1.875 Billion Credit Facilities for LifeScan Global Corporation
Date: 10/01/18
Cahill represented the lead arrangers in connection with a $1,475,000,000 first lien Term B credit facility, $125,000,000 first lien super priority revolving credit facility and $275,000,000 second lien Term B credit facility for LifeScan Global Corporation, a diagnostic systems manufacturer with products focusing on the diabetes market, specifically blood glucose monitoring systems. Proceeds from the offering were used for the acquisition of LifeScan from Johnson & Johnson by Platinum Equity.